Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/03
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 05/11/20
End: 09/28/20
Due: 09/28/21
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 07/02/20
End: 12/31/26
Due: 12/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Extracorporeal Shockwave Treatment for Chronic Soft Tissue Wounds | NCT00545896 | AUVA | user2@example.com | None | 2003-09-30 | 2010-09-30 | 2011-09-30 | - | - | 2025-07-14 |
| Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel. | NCT04354779 | AUVA | user2@example.com | None | 2020-05-11 | 2020-09-28 | 2021-09-28 | - | - | 2025-07-14 |
| Magnetic Resonance Imaging and Functional Performance Outcome After ACL Repair With Internal Brace Technique | NCT02760589 | AUVA | user2@example.com | None | 2015-11-30 | 2017-12-31 | 2018-12-31 | - | - | 2025-07-14 |
| NEUROwave - Extracorporeal Shock Wave Therapy (ESWT) in Acute Traumatic Complete (AIS A) and Incomplete (AIS B-D) Cross-sectional Lesions on Motor and Sensory Function Within Six Months After Injury | NCT04474106 | AUVA | user2@example.com | None | 2020-07-02 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |